These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 19069180)

  • 1. [Russian cycloserine in complex therapy of drug resistant tuberculosis].
    Sokolova GB; Kirtaeva OV; Lazareva IaV; Tsybanev AA
    Antibiot Khimioter; 2008; 53(5-6):32-4. PubMed ID: 19069180
    [No Abstract]   [Full Text] [Related]  

  • 2. [Rezonizat and cycloserine in complex therapy of drug resistant tuberculosis (comparative studies)].
    Sokolova GB; Lazareva IaR; Kirtaeva OV; Romanova EV; Tsybane AA
    Antibiot Khimioter; 2008; 53(11-12):25-8. PubMed ID: 19441654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cycloserine induced psychosis with hepatic dysfunction.
    Tandon VR; Rani N; Roshi ; Gupta R; Arora M; Khajuria V; Mahajan V
    Indian J Pharmacol; 2015; 47(2):230-1. PubMed ID: 25878391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A case of multi-drug resistant tuberculosis showing psychiatric adverse effect by cycloserine].
    Fujita J; Sunada K; Hayashi H; Hayashihara K; Saito T
    Kekkaku; 2008 Jan; 83(1):21-5. PubMed ID: 18283911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cycloserine-induced Stevens-Johnson syndrome in an AIDS patient with multidrug-resistant tuberculosis.
    Akula SK; Aruna AS; Johnson JE; Anderson DS
    Int J Tuberc Lung Dis; 1997 Apr; 1(2):187-90. PubMed ID: 9441086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A case of multidrug-resistant pulmonary tuberculosis].
    Tsurutani J; Sohda H; Oka M; Kohno S
    Nihon Kokyuki Gakkai Zasshi; 2000 Aug; 38(8):594-8. PubMed ID: 11061084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cycloserine-induced psychosis in a young female with drug-resistant tuberculosis.
    Sharma B; Handa R; Nagpal K; Prakash S; Gupta PK; Agrawal R
    Gen Hosp Psychiatry; 2014; 36(4):451.e3-4. PubMed ID: 24766906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychiatric issues in the management of patients with multidrug-resistant tuberculosis.
    Vega P; Sweetland A; Acha J; Castillo H; Guerra D; Smith Fawzi MC; Shin S
    Int J Tuberc Lung Dis; 2004 Jun; 8(6):749-59. PubMed ID: 15182146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Long-term results of treatment for drug-resistant pulmonary tuberculosis in socially adapted patients].
    Khodashova ML; Iuditskiĭ MV; Semenova OV
    Probl Tuberk Bolezn Legk; 2004; (3):26-8. PubMed ID: 15338896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A patient of multidrug-resistant tuberculosis on category IV treatment regimen presenting with psychosis.
    Sarkar S; Sood M
    Natl Med J India; 2011; 24(4):244-5. PubMed ID: 22208150
    [No Abstract]   [Full Text] [Related]  

  • 11. Rifabutin as salvage therapy for cases of chronic multidrug-resistant pulmonary tuberculosis in Taiwan.
    Lee CN; Lin TP; Chang MF; Jimenez MV; Dolfi L; Olliaro P
    J Chemother; 1996 Apr; 8(2):137-43. PubMed ID: 8708745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuropsychiatric toxicity and cycloserine concentrations during treatment for multidrug-resistant tuberculosis.
    Court R; Centner CM; Chirehwa M; Wiesner L; Denti P; de Vries N; Harding J; Gumbo T; Maartens G; McIlleron H
    Int J Infect Dis; 2021 Apr; 105():688-694. PubMed ID: 33684562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of kanamycin, ethionamide, PAS and cycloserine in multidrug-resistant pulmonary tuberculosis patients.
    Prasad R; Verma SK; Sahai S; Kumar S; Jain A
    Indian J Chest Dis Allied Sci; 2006; 48(3):183-6. PubMed ID: 18610675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adverse neurological reactions in patients with multidrug-resistant pulmonary tuberculosis after coadministration of cycloserine and ofloxacin.
    Yew WW; Wong CF; Wong PC; Lee J; Chau CH
    Clin Infect Dis; 1993 Aug; 17(2):288-9. PubMed ID: 8399888
    [No Abstract]   [Full Text] [Related]  

  • 15. Results of a 12-month regimen for drug-resistant pulmonary tuberculosis.
    Pérez-Guzmán C; Vargas MH; Martínez-Rossier LA; Torres-Cruz A; Villarreal-Velarde H
    Int J Tuberc Lung Dis; 2002 Dec; 6(12):1102-9. PubMed ID: 12546119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Ofloxacin-cycloserine-protionamide-INH combination against treatment refractory lung tuberculosis].
    Mühlberger F; Nturanye F; Nasbimana J; Portaels F
    Pneumologie; 1995 Feb; 49(2):72-6. PubMed ID: 7724506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical aspects and therapy of tuberculosis].
    Höffken G; Deppermann KM
    Internist (Berl); 1995 Oct; 36(10):961-9. PubMed ID: 7499072
    [No Abstract]   [Full Text] [Related]  

  • 18. Cycloserine-induced encephalopathy: evidence on brain MRI.
    Kwon HM; Kim HK; Cho J; Hong YH; Nam H
    Eur J Neurol; 2008 Jul; 15(7):e60-1. PubMed ID: 18484995
    [No Abstract]   [Full Text] [Related]  

  • 19. Safety of cycloserine and terizidone for the treatment of drug-resistant tuberculosis: a meta-analysis.
    Hwang TJ; Wares DF; Jafarov A; Jakubowiak W; Nunn P; Keshavjee S
    Int J Tuberc Lung Dis; 2013 Oct; 17(10):1257-66. PubMed ID: 23735593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [An update on the antibiotic therapy of tuberculosis].
    Rossi G
    Recenti Prog Med; 1999 May; 90(5):241-3. PubMed ID: 10380549
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.